The regulation of research by funding bodies: An emerging ethical issue for the alcohol and other drug sector?

TY - JOUR

T1 - The regulation of research by funding bodies: An emerging ethical issue for the alcohol and other drug sector?

AU - Miller, P

AU - Moore, D

AU - Strang, J

PY - 2006/1

Y1 - 2006/1

N2 - The degree to which funding bodies can and do control the content and dissemination of research products raises important issues which need to be openly debated by the alcohol and other drug (AOD) sector. Current policies relating to censorship and other means of controlling research topics or output are explored alongside an examination of how some institutions, particularly some academic journals, deal with such issues. We argue that regulation of research by funding bodies clearly contravenes the scientific ideal of freedom of information and open access to knowledge. Using international ethical guidelines, we also demonstrate that regulation raises concerns in relation to the ethical concept of beneficence. A number of examples specific to harm reduction strategies are presented in order to demonstrate how censorship might conceivably increase the harms associated with drug use. The commentary closes with recommendations concerning the establishment the prevalence of censorship and other forms of control over research in the AOD sector, and the role that ethics committees, journal editorial boards and professional societies might play in resisting the imposition of unacceptable conditions on publication of findings. (c) 2005 Elsevier B.V. All rights reserved

AB - The degree to which funding bodies can and do control the content and dissemination of research products raises important issues which need to be openly debated by the alcohol and other drug (AOD) sector. Current policies relating to censorship and other means of controlling research topics or output are explored alongside an examination of how some institutions, particularly some academic journals, deal with such issues. We argue that regulation of research by funding bodies clearly contravenes the scientific ideal of freedom of information and open access to knowledge. Using international ethical guidelines, we also demonstrate that regulation raises concerns in relation to the ethical concept of beneficence. A number of examples specific to harm reduction strategies are presented in order to demonstrate how censorship might conceivably increase the harms associated with drug use. The commentary closes with recommendations concerning the establishment the prevalence of censorship and other forms of control over research in the AOD sector, and the role that ethics committees, journal editorial boards and professional societies might play in resisting the imposition of unacceptable conditions on publication of findings. (c) 2005 Elsevier B.V. All rights reserved

U2 - 10.1016/j.drugpo.2005.10.002

DO - 10.1016/j.drugpo.2005.10.002

M3 - Editorial

VL - 17

SP - 12

EP - 16

JO - International Journal of Drug Policy

JF - International Journal of Drug Policy

IS - 1

ER -